Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings

Journal of Clinical Epidemiology

Volumn 78, Issue , 2016, Pages 90-100

  Groenwold, Rolf H H ^a   Moons, Karel G M ^a   Pajouheshnia, Romin ^a   Altman, Doug G ^b   Collins, Gary S ^b   Debray, Thomas P A ^a   Reitsma, Johannes B ^a   Riley, Richard D ^c   Peelen, Linda M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

Author keywords

Calibration; Computer simulation; Decision support techniques; Models; Prognosis; Statistical

Indexed keywords

ANALYTICAL DATA SET TO UNTREATED INDIVIDUAL; ARTICLE; CLINICAL DECISION MAKING; COMPUTER SIMULATION; EXPLICIT MODELING OF TREATMENT; HUMAN; INVERSE PROBABILITY WEIGHTING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROBABILITY; PROGNOSTIC ASSESSMENT; RANDOMIZATION; SIMPLY IGNORING TREATMENT; STATISTICAL MODEL; TREATMENT OUTCOME; EPIDEMIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA;

COMPUTER SIMULATION; EPIDEMIOLOGIC STUDIES; HUMANS; MODELS, STATISTICAL; OBSERVATIONAL STUDIES AS TOPIC; PROBABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84964613609     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.03.017     Document Type: Article

References (15)

1. [1] Moons, K.G., Altman, D.G., Vergouwe, Y., Royston, P., Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ, 338, 2009, b606.
2. [2] Campbell, W., Ganna, A., Ingelsson, E., Janssens, A.C., Prediction impact curve is a new measure integrating intervention effects in the evaluation of risk models. J Clin Epidemiol 69 (2015), 89–95.
3. [3] Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, M., et al., European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33 (2012), 1635–1701.
4. [4] Hemingway, H., Croft, P., Perel, P., Hayden, J.A., Abrams, K., Timmis, A., et al., PROGRESS Group. Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ, 346, 2013, e5595.
5. [5] Liew, S.M., Doust, J., Glasziou, P., Cardiovascular risk scores do not account for the effect of treatment: a review. Heart 97 (2011), 689–697.
6. [6] Frankel, M.R., Morgenstern, L.B., Kwiatkowski, T., Lu, M., Tilley, B.C., Broderick, J.P., et al. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and stroke rt-Pa stroke trial. Neurology 55 (2000), 952–959.
7. [7] Lawton, M., Tilling, K., Robertson, N., Tremlett, H., Zhu, F., Harding, K., et al. A longitudinal model for disease progression was developed and applied to multiple sclerosis. J Clin Epidemiol 68 (2015), 1355–1365.
8. [8] van Leeuwen, N., Lingsma, H.F., Perel, P., Lecky, F., Roozenbeek, B., Lu, J., et al., International Mission on Prognosis and Clinical Trial Design in TBI Study Group; Corticosteroid Randomization After Significant Head Injury Trial Collaborators; Trauma Audit and Research Network. Prognostic value of major extracranial injury in traumatic brain injury: an individual patient data meta-analysis in 39,274 patients. Neurosurgery 70 (2012), 811–818.
9. [9] Collins, G.S., Reitsma, J.B., Altman, D.G., Moons, K.G., Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. J Clin Epidemiol 68 (2015), 134–143.
10. [10] R Development Core Team. R: a language and environment for statistical computing. 2008, R Foundation for Statistical Computing, Vienna, Austria 3-900051-07-0.
11. [11] Smith, G.D., Lawlor, D.A., Harbord, R., Timpson, N., Day, I., Ebrahim, S., Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PloS Med, 4(12), 2007, e352.
12. [12] Steyerberg, E.W., Clinical prediction models: a practical approach to development, validation, and updating. 2009, Springer, New York.
13. [13] Brier, G.W., Verification of forecasts expressed in terms of probability. Mon Wea Rev 78 (1950), 1–3.
14. [14] Harrell, F.E. Jr., Lee, K.L., Califf, R.M., Pryor, D.B., Rosati, R.A., Regression modelling strategies for improved prognostic prediction. Stat Med 3 (1984), 143–152.
15. [15] Cook, N.R., Ridker, P.M., Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study. JAMA Intern Med 174 (2014), 1964–1971.